Ginger's Therapeutic Potential in Asthma

Part of paid clinical trials in New York, New York.

Sponsor: Emily DiMango, MD
Study ID: NCT07792395
Phase: PHASE2
Status: Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Asthma

Eligibility Criteria

Sex: ALL
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Interventions

Ginger Extract — DRUG
2gm or 3gm capsule of Ginger Extract
Placebo — DRUG
Matching placebo

Study Details

Primary Objective: The primary endpoint is a clinically significant improvement in tolerance to inhaled methacholine (PD20). Secondary Objectives: 1) To determine if oral daily ginger extract intake - decreases fractional excretion of nitric oxide; decreases blood eosinophilia; decreases asthma-associated cytokines in serum; decreases medium chain fatty acids; improves asthma symptoms; and 2) Establish pharmacokinetic parameters of biologically active components of ginger in adult asthmatics.

Key Dates

First listed: Aug 28, 2026
Start date: Nov 30, 2026
Status verified: Aug 2026
Primary completion: Dec 31, 2028
Completion: Mar 31, 2029

Study Design

Enrollment: 32 participants (estimated)
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: TREATMENT

Arms

Experimental: Active drug - Placebo (2gm)
Subjects assigned to the intervention will receive 2 grams daily of Ginger Extract for 56 days, followed by washout period, then will receive matching placebo for 56 days.
Experimental: Placebo - Active Drug (2gm)
Subjects assigned to the placebo group will receive a matching placebo for 56 days, followed by washout period, then will receive 2 grams daily of Ginger Extract for 56 days.
Experimental: Active drug - Placebo (3gm)
Subjects assigned to the intervention will receive 3 grams daily of Ginger Extract for 56 days, followed by washout period, then will receive matching placebo for 56 days.
Experimental: Placebo - Active Drug (3gm)
Subjects assigned to the placebo group will receive a matching placebo for 56 days, followed by washout period, then will receive 3 grams daily of Ginger Extract for 56 days.